ANI Pharmaceuticals, Inc. (ANIP) Profit Margins
Over the twelve months to 2026-06-30, ANI Pharmaceuticals, Inc. (ANIP) had gross margin 60.4%, operating margin 15.4%, net margin 11.1%, free cash flow margin 17.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ANIPANI Pharmaceuticals, Inc.Follow ANIP — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- 15.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 66.8% | 79.5% | 83.4% | 62.1% | 55.3% | 63.8% | 69.4% | 58.2% | 53.5% | 56.1% | 62.7% | 59.3% | 61.4% | 60.4% | |
| Operating margin | — | — | 3.0% | 35.7% | 42.8% | 15.6% | 16.0% | 17.5% | 7.9% | -7.7% | -18.4% | -11.2% | 9.6% | 0.1% | 12.6% | 15.4% | |
| Net margin | -11859.7% | -41.7% | 1.0% | 51.4% | 20.1% | 3.1% | -0.6% | 7.7% | 3.0% | -10.8% | -19.7% | -15.1% | 3.9% | -3.0% | 8.9% | 11.1% | |
| FCF margin | -11166.0% | -1.4% | -18.9% | 37.4% | 19.8% | 17.8% | 16.4% | 30.4% | 18.9% | 4.4% | 0.4% | -12.7% | 22.6% | 7.8% | 19.4% | 17.7% |
USD billions · SEC XBRL
ANI Pharmaceuticals, Inc. — questions
- What is ANI Pharmaceuticals, Inc.'s gross margin?
- 60.4% over the twelve months to 2026-06-30.
- What is ANI Pharmaceuticals, Inc.'s operating margin?
- 15.4% over the twelve months to 2026-06-30.
- What is ANI Pharmaceuticals, Inc.'s net profit margin?
- 11.1% over the twelve months to 2026-06-30.
Every figure on this page comes from ANI Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.